Geneva Partners’s Lam Research LRCX Stock Holding History

Geneva Partners’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.65M	Buy	+12,398	New	+$2.77M	1.27%	27
2024 Q3	–	Sell	-43,630	Closed	-$4.65M	–	77
2024 Q2	$4.65M	Buy	43,630 +28,440	+187%	+$2.73M	1.91%	21
2024 Q1	$1.48M	Buy	15,190 +3,190	+27%	+$281K	0.65%	43
2023 Q4	$940K	Sell	12,000 -10,240	-46%	-$698K	0.52%	45
2023 Q3	$1.39M	Buy	22,240 +9,050	+69%	+$595K	0.93%	33
2023 Q2	$848K	Buy	+13,190	New	+$743K	0.55%	42
2020 Q1	–	Sell	-16,100	Closed	-$471K	–	69
2019 Q4	$471K	Buy	+16,100	New	+$428K	0.33%	57

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneva Partners's LRCX Position: Q1 2026 in Review

Geneva Partners opened a new position in Lam Research (LRCX) in Q1 2026: 12,398 shares worth $2.65M. The stake represents 1.27% of the portfolio and ranks #27 among its holdings. This is a return to the name: Geneva Partners previously reported a position in LRCX as recently as Q2 2024.

Geneva Partners first reported a position in LRCX in Q4 2019 and has held it in 7 quarters since. The position peaked at $4.65M in Q2 2024. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Geneva Partners held 12,398 shares of Lam Research worth $2.65M as of Q1 2026.
Lam Research was a new Geneva Partners position in Q1 2026.
Lam Research made up 1.27% of Geneva Partners's portfolio in Q1 2026, its #27 holding.
Geneva Partners first reported a position in Lam Research in Q4 2019 and has held it in 7 quarters since.
Geneva Partners's Lam Research position peaked at $4.65M in Q2 2024.
2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Geneva Partners's 13F filing for Q1 2026, filed 29 Apr 2026.